“…Unlike many other kinase substrates, the 80-kDa substrate appears to be an exclusive PKC substrate (Albert et a]., 1986;Blackshear et al, 1985;Rozengurt et al, 1983) and, as such, it has been widely used as a marker of PKC activation in vivo (Niedel and Blackshear, 1986). The protein is myristoylated (Aderem et al, 1988;James and Olson, 1989; McInhinney and McGlone, 1990) and, based on recently reported sequence data, it has an unusual amino acid composition [e.g., contains 20% glutamic acid and 25% alanine) and a true molecular mass of 32 kDa (Stumpo et al, 1989) (Simek et al, 1989;Wolfman et al, 1987;Yang and Pardee, 1987), lymphocyte development and activation (Hornbeck et al, 1989), inflammatory response in human neutrophills , and neurite outgrowth in neuroblastoma cells (Girard and Kuo, 1990), suggesting a role for this protein in cell growth and differentiation.We recently demonstrated a marked stimulation by PMA of DNA synthesis, cell proliferation (Bhat, 1989), and c-fos proto-oncogene induction (Bhat et al, in press) in cultured oligodendroglial (OL) progenitors. The effects of PMA seemed to be mediated by an activation of PKC, as suggested by a reversal of cell responses to PMA by inhibitors of PKC, The present report deals with protein phosphorylation in OL progenitors stimulated with PMA and the identification by immunochemical means of a major phosphoprotein as the specific PKC substrate, i.e., MARCKS protein.…”